FDA is developing a standardized policy on how frequently participants in Risk Evaluation and Mitigation Strategy programs should re-enroll and recertify in order to keep their participation current.
The policy is part of FDA efforts to standardize REMS programs in response to stakeholder complaints about the burden on the health care community that results from varying requirements among...